Amgen Inc
NASDAQ:AMGN

Watchlist Manager
Amgen Inc Logo
Amgen Inc
NASDAQ:AMGN
Watchlist
Price: 263.38 USD 0.84% Market Closed
Market Cap: 141.6B USD
Have any thoughts about
Amgen Inc?
Write Note

Intrinsic Value

The intrinsic value of one AMGN stock under the Base Case scenario is 250.37 USD. Compared to the current market price of 263.38 USD, Amgen Inc is Overvalued by 5%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

AMGN Intrinsic Value
250.37 USD
Overvaluation 5%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Amgen Inc

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
AMGN
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for AMGN cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
How do you feel about AMGN?
Bearish
Neutral
Bullish

Fundamental Analysis

263.38 USD
+0.84%
+0.84%
Benchmark
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Amgen Inc
US
Biotechnology
Market Cap
141.6B USD
IPO
Jun 17, 1983
Employees
24 200
United States of America
Market Cap
141.6B USD
Industry
Biotechnology
IPO
Jun 17, 1983
Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about Amgen Inc

Provide an overview of the primary business activities
of Amgen Inc.

What unique competitive advantages
does Amgen Inc hold over its rivals?

What risks and challenges
does Amgen Inc face in the near future?

Has there been any significant insider trading activity
in Amgen Inc recently?

Summarize the latest earnings call
of Amgen Inc.

What significant events have occurred
in Amgen Inc over the past months?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Amgen Inc.

Provide P/S
for Amgen Inc.

Provide P/E
for Amgen Inc.

Provide P/OCF
for Amgen Inc.

Provide P/FCFE
for Amgen Inc.

Provide P/B
for Amgen Inc.

Provide EV/S
for Amgen Inc.

Provide EV/GP
for Amgen Inc.

Provide EV/EBITDA
for Amgen Inc.

Provide EV/EBIT
for Amgen Inc.

Provide EV/OCF
for Amgen Inc.

Provide EV/FCFF
for Amgen Inc.

Provide EV/IC
for Amgen Inc.

Show me price targets
for Amgen Inc made by professional analysts.

What are the Revenue projections
for Amgen Inc?

How accurate were the past Revenue estimates
for Amgen Inc?

What are the Net Income projections
for Amgen Inc?

How accurate were the past Net Income estimates
for Amgen Inc?

What are the EPS projections
for Amgen Inc?

How accurate were the past EPS estimates
for Amgen Inc?

What are the EBIT projections
for Amgen Inc?

How accurate were the past EBIT estimates
for Amgen Inc?

Compare the revenue forecasts
for Amgen Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Amgen Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Amgen Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Amgen Inc compared to its peers.

Compare the P/E ratios
of Amgen Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Amgen Inc with its peers.

Analyze the financial leverage
of Amgen Inc compared to its main competitors.

Show all profitability ratios
for Amgen Inc.

Provide ROE
for Amgen Inc.

Provide ROA
for Amgen Inc.

Provide ROIC
for Amgen Inc.

Provide ROCE
for Amgen Inc.

Provide Gross Margin
for Amgen Inc.

Provide Operating Margin
for Amgen Inc.

Provide Net Margin
for Amgen Inc.

Provide FCF Margin
for Amgen Inc.

Show all solvency ratios
for Amgen Inc.

Provide D/E Ratio
for Amgen Inc.

Provide D/A Ratio
for Amgen Inc.

Provide Interest Coverage Ratio
for Amgen Inc.

Provide Altman Z-Score Ratio
for Amgen Inc.

Provide Quick Ratio
for Amgen Inc.

Provide Current Ratio
for Amgen Inc.

Provide Cash Ratio
for Amgen Inc.

What is the historical Revenue growth
over the last 5 years for Amgen Inc?

What is the historical Net Income growth
over the last 5 years for Amgen Inc?

What is the current Free Cash Flow
of Amgen Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Amgen Inc.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Amgen Inc

Current Assets 26.8B
Cash & Short-Term Investments 9B
Receivables 7.3B
Other Current Assets 10.4B
Non-Current Assets 64.1B
PP&E 6.2B
Intangibles 47.6B
Other Non-Current Assets 10.4B
Current Liabilities 20.3B
Accounts Payable 18.9B
Accrued Liabilities 14.6B
Other Current Liabilities -13.2B
Non-Current Liabilities 63B
Long-Term Debt 56.9B
Other Non-Current Liabilities 6.2B
Efficiency

Earnings Waterfall
Amgen Inc

Revenue
32.5B USD
Cost of Revenue
-12.9B USD
Gross Profit
19.7B USD
Operating Expenses
-13.4B USD
Operating Income
6.2B USD
Other Expenses
-2B USD
Net Income
4.2B USD

Free Cash Flow Analysis
Amgen Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

AMGN Profitability Score
Profitability Due Diligence

Amgen Inc's profitability score is 73/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROE
Positive Free Cash Flow
Positive Gross Profit
Exceptional ROE
73/100
Profitability
Score

Amgen Inc's profitability score is 73/100. The higher the profitability score, the more profitable the company is.

AMGN Solvency Score
Solvency Due Diligence

Amgen Inc's solvency score is 35/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Low Altman Z-Score
Positive Net Debt
35/100
Solvency
Score

Amgen Inc's solvency score is 35/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

AMGN Price Targets Summary
Amgen Inc

Wall Street analysts forecast AMGN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for AMGN is 336.33 USD with a low forecast of 196.95 USD and a high forecast of 425.25 USD.

Lowest
Price Target
196.95 USD
25% Downside
Average
Price Target
336.33 USD
28% Upside
Highest
Price Target
425.25 USD
61% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for AMGN?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Previous Payment
-
Today
Next Payment
-
Today
Dec 22, 2024
Previous Payment
-
Next Payment
-
Ex-Dividend Date
-
Shareholder Yield

Current shareholder yield for AMGN is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

AMGN Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

AMGN News

Other Videos

See Also

Discover More
What is the Intrinsic Value of one AMGN stock?

The intrinsic value of one AMGN stock under the Base Case scenario is 250.37 USD.

Is AMGN stock undervalued or overvalued?

Compared to the current market price of 263.38 USD, Amgen Inc is Overvalued by 5%.

Back to Top